# US 2021/0277465 A1 · Methods and systems for processing polynucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277465 A1
- Document ID: US20210277465A1
- Status: Published application
- Kind: A1
- Application number: 17/314,526
- Filed: 2021-05-07
- Published: 2021-09-09
- Earliest claimed: 2012-08-14
- Assignees: 10x Genomics, Inc.
- Applicants: 10X Genomics, Inc.
- Inventors: Benjamin Hindson; Christopher Hindson; Michael Schnall-Levin; Kevin Ness; Mirna Jarosz; Serge Saxonov; Paul Hardenbol
- Web page: https://patentgrep.com/patent/US20210277465A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6855: Ligating adaptors
- C12Q 1/6869: Methods for sequencing
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing.

## Claims

### Claim 1

A method for processing messenger ribonucleic acid (mRNA) molecules from a single cell, comprising:
(a) partitioning a plurality of cells and a plurality of beads in a plurality of wells, wherein a well of said plurality of wells comprises said single cell from said plurality of cells and a single bead from said plurality of beads, and wherein said single bead comprises nucleic acid barcode molecules each comprising a common barcode sequence;
(b) in said well comprising said single cell and said single bead, releasing messenger ribonucleic acid (mRNA) molecules from said single cell, wherein upon release from said single cell, said mRNA molecules attach to said nucleic acid barcode molecules;
(c) subjecting said mRNA molecules attached to said nucleic acid barcode molecules to reverse transcription to yield complementary deoxyribonucleic acid (cDNA) molecules each comprising said common barcode sequence; and
(d) subjecting said cDNA molecules to one or more reactions to generate a set of nucleic acid molecules for nucleic acid sequencing.

### Claim 2 (depends on 1)

The method of claim 1, wherein (c) is performed in said well comprising said single cell and said single bead, and wherein subsequent to (c), said cDNA molecules, or derivatives thereof, are removed from said given well.

### Claim 3 (depends on 1)

The method of claim 1, wherein, prior to (c), said mRNA molecules attached to said nucleic acid barcode molecules are removed from said well comprising said single cell and said single bead.

### Claim 4 (depends on 1)

The method of claim 1, wherein each of said nucleic acid barcode molecules comprises a universal primer sequence.

### Claim 5 (depends on 1)

The method of claim 1, wherein said single bead is a single magnetic bead.

### Claim 6 (depends on 5)

The method of claim 5, wherein said nucleic acid barcode molecules are attached to said single magnetic bead.

### Claim 7 (depends on 6)

The method of claim 6, wherein prior to (c), said single magnetic bead comprising said mRNA molecules attached to said nucleic acid barcode molecules are removed from said well comprising said single cell and said single bead.

### Claim 8 (depends on 7)

The method of claim 7, wherein said single magnetic bead is removed using a magnetic field.

### Claim 9 (depends on 1)

The method of claim 1, wherein each of said nucleic acid barcode molecules comprises a sequence for priming the synthesis of cDNA.

### Claim 10 (depends on 9)

The method of claim 9, wherein said RNA priming sequence is poly-T sequence.

### Claim 11 (depends on 1)

The method of claim 1, wherein said plurality of cells comprises at least 100 cells.

### Claim 12 (depends on 1)

The method of claim 1, wherein said plurality of cells comprises at least 1,000 cells.

### Claim 13 (depends on 1)

The method of claim 1, wherein said plurality of cells comprises at least 10,000 cells.

### Claim 14 (depends on 1)

The method of claim 1, wherein said mRNA molecules attach to said nucleic acid barcode molecules by hybridization.

### Claim 15 (depends on 1)

The method of claim 1, wherein said plurality of beads comprises a plurality of nucleic acid barcode molecules comprising barcode sequences that are different across said plurality of beads.

### Claim 16 (depends on 1)

The method of claim 1, further comprising, prior to (c), (i) pooling said mRNA molecules attached to said nucleic acid barcode molecules and (ii) performing said one or more reactions in bulk.

### Claim 17 (depends on 1)

The method of claim 1, wherein said one or more reactions comprise nucleic acid amplification that generates amplified products from said plurality of cDNA molecules.

### Claim 18 (depends on 17)

The method of claim 17, further comprising purifying said amplified products.

### Claim 19 (depends on 17)

The method of claim 17, wherein said nucleic acid amplification adds functional sequences to said amplified products, wherein said functional sequences permit attachment of said amplified products to a flow cell of a sequencer for said nucleic acid sequencing.

### Claim 20 (depends on 17)

The method of claim 17, further comprising ligating functional sequences to said amplified products, wherein said functional sequences permit attachment of said amplified products to a flow cell of a sequencer for said nucleic acid sequencing.

### Claim 21 (depends on 17)

The method of claim 17, wherein said nucleic acid amplification is polymerase chain reaction.

### Claim 22 (depends on 1)

The method of claim 1, wherein said one or more reactions comprise addition of functional sequences to said plurality of cDNA molecules, wherein said functional sequences permit attachment to a flow cell of a sequencer for said nucleic acid sequencing.

### Claim 23 (depends on 1)

The method of claim 1, further comprising performing said nucleic acid sequencing on said set of nucleic acid molecules, or derivatives thereof, to generate a plurality of sequences comprising sequences corresponding to said mRNA molecules and said common barcode sequence.

### Claim 24 (depends on 1)

The method of claim 1, wherein said plurality of beads have substantially monodisperse cross-sectional dimensions.

### Claim 25 (depends on 1)

The method of claim 1, wherein each of said nucleic acid barcode molecules comprise said common barcode sequence and a unique molecular sequence, wherein said common barcode sequence is constant across said nucleic acid barcode molecules, and wherein said unique molecular sequence varies across said nucleic acid barcode molecules.

### Claim 26 (depends on 25)

The method of claim 25, wherein each of said nucleic acid barcode molecules further comprise a sequence for priming the synthesis of cDNA.

### Claim 27 (depends on 26)

The method of claim 26, wherein said RNA priming sequence is a poly-T sequence.

### Claim 28 (depends on 1)

The method of claim 1, wherein said nucleic acid barcode molecules further comprise functional sequences that facilitate sequencing of said set of nucleic acid molecules.
